Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
04/2005
04/20/2005CN1608054A Therapeutic quinolone compounds with 5-HT-antagonistic properties
04/20/2005CN1607951A Quinoline derivatives as neuropeptide y antagonists
04/20/2005CN1197860C FAB I inhibitors
04/20/2005CN1197855C Organic compound with bi-4-dicyan methylene pyranoid ring and its synthetic method and use
04/20/2005CN1197849C 2, 3, 4, 5-tetrahydro-1H-[1, 4] benzodiazepine-3-hydroxamic acid as matrix metalloproteinase inhibitors
04/20/2005CN1197458C Herbicidal synergic composition and method for controlling weed
04/19/2005US6881753 Potassium channel inhibitors and method
04/19/2005US6881747 Small molecules for inhibition of function and drug delivery to leukocytes
04/19/2005US6881743 Pyridine matrix metalloproteinase inhibitors
04/19/2005US6881740 Pharmaceutical agents
04/19/2005US6881733 Serotonergic benzofurans
04/19/2005US6881727 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same
04/19/2005US6881536 Particle based electrochemiluminescent assays
04/14/2005WO2005033330A2 Fluorescent probes for use in protein kinase inhibitor binding assay
04/14/2005WO2005033105A2 Vanilloid receptor ligands and their use in treatments
04/14/2005WO2005033101A1 Novel p-glycoprotein inhibitor, method for the preparation thereof and pharmaceutical composition comprising the same
04/14/2005WO2005033097A1 P-glycoprotein inhibitor, method for preparing the same and pharmaceutical composition comprising the same
04/14/2005WO2005033096A1 Quinoline derivatives and quinazoline derivatives, medicaments containing said compounds, use thereof, and method for the production thereof
04/14/2005WO2005033093A1 7,8-bicycloalkyl-chroman derivatives
04/14/2005WO2005033092A1 Chroman derivatives
04/14/2005WO2005033065A1 Novel amidine compounds for treating microbial infections
04/14/2005WO2005032594A2 Alkylators linked to polyamides as dna binding agents
04/14/2005WO2005032548A1 Substituted benzazoles and use thereof as inhibitors of raf kinase
04/14/2005WO2005032493A2 Amide compounds as ion channel ligands and uses thereof
04/14/2005WO2005032484A2 Alkoxy substituted imidazoquinolines
04/14/2005WO2005032471A2 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
04/14/2005WO2005016883A3 Acrylamide derivatives as vla-1 integrin antagonists and uses thereof
04/14/2005WO2005007111A3 Tetrahydroquinoline derivatives as cannabinoid receptor modulators
04/14/2005WO2004013120A8 Novel benzodioxoles
04/14/2005US20050080265 Sleep disorders; side effect reduction
04/14/2005US20050080260 Preparation of prodrugs for selective drug delivery
04/14/2005US20050080258 Kinase inhibitors; autoimmune disease; antiinflammatory agents
04/14/2005US20050080129 Derivatives of andrimide and moiramide b having antibacterial properties
04/14/2005US20050080127 for the prophylaxis and therapy of osteoarthritis and rheumatism
04/14/2005US20050080124 Treating sleep disorders insomnia; 1-[3-(4-Bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(4-chloro-phenyl)-urea; restless leg syndrome, cardiovascular disorders, reducing blood clot
04/14/2005US20050080121 for example, 4S-[(naphthalene-2-carbonyl)-amino]-5-(2-oxo-pyrrolidin-3S-yl)-pent-2-enoic acid ethyl ester; treatment of viral infections caused by human rhinoviruses, human polioviruses, human coxsackieviruses, human echoviruses, among others
04/14/2005US20050080111 Antagonists of liver X receptors; control of cholesterol, triglyceride, or bile acid levels; 6-(1-Benzyl-1H-pyrazol-4-yl)-1-(2,4-difluoro-benzyl)-2-oxo-4-trifluoromethyl-1,2-dihydro-pyridine-3-carbonitrile
04/14/2005US20050080110 Treating Type 2 diabetes and/or obesity; compounds are indoles substituted at position 3 with a (3-(2-(heterocycle-substituted)phenoxy)-2-hydroxypropylamino)alkyl group
04/14/2005US20050080108 such as (S)-1-ethyl-5-[(4'-trifluoromethyl-biphenyl-2-carbonyl)-amino]-1H-indole-2-carboxylic acid-[2-[benzyl(methyl)amino]-2-oxo-1-phenylethyl]amide; for treatment of obesity and lipid disorders; diabetes
04/14/2005US20050080106 Such as 2-[3,5-Di(2-chlorobenzyloxy)benzoyl)amino]-thiazole; for treatment of diabetes
04/14/2005US20050080101 N-[4-(pyrazolyl)-pyrimidin-2-yl]-N-phenyl-amine derivatives
04/14/2005US20050080095 Novel amides useful for treating pain
04/14/2005US20050080088 Novel compounds
04/14/2005US20050080087 For treatment of metabolic disorders, eating disorders, appetitive disorders, psychiatric disorders, memory impairment, Parkinson's disease, Alzheimer's disease, substance abuse, leukocyte activation-associated disorders, and inflammatory diseases
04/14/2005US20050080078 Such as [1-(4-chloro-phenyl)-cyclobutyl]-(3-hydroxymethyl piperidin-1-yl)-methadone for treating cocaine and/or methamphetamine addiction
04/14/2005US20050079455 Colour photographic recording material
04/14/2005DE10342503A1 Benzyl-Benzimidazolylderivate Benzyl-Benzimidazolylderivate
04/14/2005CA2541822A1 Novel hypocholesterolemic compounds
04/14/2005CA2541299A1 Amide compounds as ion channel ligands and uses thereof
04/14/2005CA2541059A1 Fluorescent probes for use in protein kinase inhibitor binding assay
04/14/2005CA2540640A1 Vanilloid receptor ligands and their use in treatments
04/14/2005CA2540452A1 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
04/14/2005CA2539748A1 Substituted benzazoles and use thereof as inhibitors of raf kinase
04/14/2005CA2537791A1 Novel amidine compounds for treating microbial infections
04/13/2005EP1522540A1 Azaarene derivatives
04/13/2005EP1521751A1 Substituted 3-cyanoquinolines as mek inhibitors
04/13/2005EP1521750A1 Novel macrocycles for the treatment of cancer diseases
04/13/2005EP1521747A2 Receptor-type kinase modulators and methods of use
04/13/2005EP1521582A1 2,5-substituted pyrimidine derivatives as ccr-3 receptor antagonists
04/13/2005EP1289955B1 Piperidines for use as orexin receptor antagonists
04/13/2005EP1077938B1 2-(2-methylphenyl)-3,4-dihydro-2h-pyrrol derivatives
04/13/2005EP0880507B1 Quinazoline derivatives as antitumor agents
04/13/2005CN1606555A Imidazoquinoline derivatives
04/13/2005CN1606551A Substituted 2-phenyl benzofurans as estrogenic agents
04/13/2005CN1606544A Bicyclic compound
04/13/2005CN1606439A Cis-imidazolines
04/13/2005CN1196697C Thiophene-ethyl thiourea compounds and their use in treatment of HIV
04/13/2005CN1196694C Polymerisable, optically active dioxolane diesters
04/13/2005CN1196692C Substituted benzopyran derivatives for the treatment of inflammation
04/13/2005CN1196685C Pyrimidine derivatives
04/13/2005CN1196681C (+)-Norcisapride useful for 5-HT3 and 5-HT4 mediated disorbers
04/12/2005US6878831 Optical resolution
04/12/2005US6878736 Histamine H3 receptor ligands
04/12/2005US6878727 Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
04/12/2005US6878721 Beta2-adrenoceptor agonists
04/12/2005US6878720 VEGF receptor tyrosine kinase inhibitors
04/12/2005US6878718 Able to inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders
04/12/2005US6878714 Prophylaxis and treatment of angiogenesis mediated diseases such as cancer
04/12/2005US6878709 Treating acute and chronic inflammatory disorders and cancer.
04/12/2005CA2293247C 4-phenylpiperidine compounds
04/12/2005CA2081836C Aromatic amidine derivatives and salts thereof
04/07/2005WO2005030794A2 Hemiasterlin derivatives and uses thereof
04/07/2005WO2005030765A1 Quinazoline derivatives as antiproliferative agents
04/07/2005WO2005030762A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
04/07/2005WO2005030761A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
04/07/2005WO2005030760A1 Substituted heteroaryl benzofuran acids
04/07/2005WO2005030759A1 Carbamoyl-type benzofuran derivatives
04/07/2005WO2005030757A1 Quinazoline derivatives
04/07/2005WO2005030735A1 Triazines derivatives as cell adhesion inhibitors
04/07/2005WO2005030734A1 Diaminopyrimidine derivatives as selective growth hormone secrectgogue receptor (ghs-r) antagonists
04/07/2005WO2005030733A1 Benzimidazole derivatives, compositions containing them, preparation therof and uses thereof
04/07/2005WO2005030732A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
04/07/2005WO2005030729A1 Isoquinoline potassium channel inhibitors
04/07/2005WO2005030728A1 Bicyclic imino acid derivatives used as inhibitors of matrix-metalloproteinases
04/07/2005WO2005030725A1 Derivatives of 3-aminocarbonylquinoline, pharmaceutical compositions containing them and processes and intermediates for their preparation
04/07/2005WO2005030712A2 Thrombin receptor antagonists
04/07/2005WO2005030702A1 Biphenyloxy-acids
04/07/2005WO2005030216A1 5-arylpyrimidines as anticancer agents
04/07/2005WO2005030213A1 1,1,1-trifluoro-4-phenyl-4-methyl-2-(1h-pyrrolo
04/07/2005WO2005030212A1 4-aminoquinoline-3-carboxamide derivatives as pde4 inhibitors
1 ... 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 ... 694